1. Home
  2. SGHT vs PSNYW Comparison

SGHT vs PSNYW Comparison

Compare SGHT & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • PSNYW
  • Stock Information
  • Founded
  • SGHT 2011
  • PSNYW N/A
  • Country
  • SGHT United States
  • PSNYW Sweden
  • Employees
  • SGHT N/A
  • PSNYW 2515
  • Industry
  • SGHT Medical Specialities
  • PSNYW Auto Manufacturing
  • Sector
  • SGHT Health Care
  • PSNYW Consumer Discretionary
  • Exchange
  • SGHT Nasdaq
  • PSNYW Nasdaq
  • Market Cap
  • SGHT 304.4M
  • PSNYW 324.1M
  • IPO Year
  • SGHT 2021
  • PSNYW N/A
  • Fundamental
  • Price
  • SGHT $2.89
  • PSNYW $0.23
  • Analyst Decision
  • SGHT Buy
  • PSNYW
  • Analyst Count
  • SGHT 7
  • PSNYW 0
  • Target Price
  • SGHT $5.10
  • PSNYW N/A
  • AVG Volume (30 Days)
  • SGHT 260.5K
  • PSNYW N/A
  • Earning Date
  • SGHT 03-06-2025
  • PSNYW N/A
  • Dividend Yield
  • SGHT N/A
  • PSNYW N/A
  • EPS Growth
  • SGHT N/A
  • PSNYW N/A
  • EPS
  • SGHT N/A
  • PSNYW N/A
  • Revenue
  • SGHT $79,543,000.00
  • PSNYW N/A
  • Revenue This Year
  • SGHT $2.13
  • PSNYW N/A
  • Revenue Next Year
  • SGHT $7.99
  • PSNYW N/A
  • P/E Ratio
  • SGHT N/A
  • PSNYW N/A
  • Revenue Growth
  • SGHT N/A
  • PSNYW N/A
  • 52 Week Low
  • SGHT $2.68
  • PSNYW N/A
  • 52 Week High
  • SGHT $8.45
  • PSNYW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 26.68
  • PSNYW 60.29
  • Support Level
  • SGHT $2.68
  • PSNYW $0.20
  • Resistance Level
  • SGHT $3.34
  • PSNYW $0.24
  • Average True Range (ATR)
  • SGHT 0.16
  • PSNYW 0.04
  • MACD
  • SGHT -0.03
  • PSNYW 0.00
  • Stochastic Oscillator
  • SGHT 20.38
  • PSNYW 34.75

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Share on Social Networks: